- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- October 2023
- 84 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- May 2022
- 44 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- May 2022
- 45 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- May 2022
- 38 Pages
Global
From €2417EUR$2,500USD£2,076GBP
Vasopressin is a hormone used in the treatment of gastrointestinal disorders. It is used to treat conditions such as gastroparesis, a condition in which the stomach does not empty properly, and to reduce the risk of aspiration in patients with gastroesophageal reflux disease. It is also used to treat diarrhea caused by certain medications. Vasopressin is available in both oral and injectable forms.
Vasopressin is used in combination with other medications to treat a variety of gastrointestinal disorders. It is often used in combination with proton pump inhibitors to reduce the risk of aspiration in patients with gastroesophageal reflux disease. It is also used in combination with antibiotics to treat diarrhea caused by certain medications.
Vasopressin is available from a variety of pharmaceutical companies, including Novartis, Pfizer, and Merck. It is also available in generic forms from several generic drug manufacturers. Show Less Read more